Chad Gassert - 12 Feb 2026 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
SVP - CORP. DEV. & STRATEGY
Signature
/s/ Chad Gassert, by attorney-in-fact Meredith W. Cook
Issuer symbol
ANIP
Transactions as of
12 Feb 2026
Net transactions value
-$256,161
Form type
4
Filing time
17 Feb 2026, 16:05:51 UTC
Previous filing
13 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gassert Chad SVP - CORP. DEV. & STRATEGY C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE /s/ Chad Gassert, by attorney-in-fact Meredith W. Cook 17 Feb 2026 0001871002

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $123,334 -1,608 -2.3% $76.70 67,738 12 Feb 2026 Direct F1
transaction ANIP Common Stock Tax liability $132,827 -1,717 -2.5% $77.36 66,021 14 Feb 2026 Direct F2
holding ANIP Common Stock 158,490 12 Feb 2026 Held by Chali Properties LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,590 shares of restricted stock, the grant of which was previously reported on February 18, 2025.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,355 shares of restricted stock, the grant of which was previously reported on February 16, 2024.
F3 The reporting person holds voting and dispositive power over the shares held by Chali Properties LLC.